Can we stratify cardiovascular risk in Argentina?;¿Podemos estratificar el riesgo cardiovascular en la población Argentina?

Revista Argentina de Cardiologia

Volumn 82, Issue 6, 2014, Pages 449-451

  Santos Gallego, Carlos G ^a   Badimón, Juan J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LINISOPRIL; UNCLASSIFIED DRUG;

ASCVD; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; EDITORIAL; FRAMINGHAM RISK SCORE; HEALTH CARE COST; HUMAN; MORBIDITY; MORTALITY; NHANESI; POPULATION RISK; PRACTICE GUIDELINE; PROCAM SCORE; QRISK SCORE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORE; SYSTOLIC BLOOD PRESSURE;

EID: 84925345048     PISSN: 00347000     EISSN: 18503748     Source Type: Journal    
DOI: 10.7775/rac.v82.i6.5473     Document Type: Editorial

References (17)

1. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62. http://doi.org/wwj
2. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47. http://doi.org/m5c
3. D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743-53. http://doi.org/dthnkd
4. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003. http://doi.org/fksv94
5. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335:136. http://doi.org/d2qm5m
6. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year followup of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002;105:310-5. http://doi.org/dzrhzs
7. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008;371:923-31. http://doi.org/bqfz45
8. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129(25 Suppl 2):S1-45. http://doi.org/wwk
9. Marrugat J, Subirana I, Comin E, Cabezas C, Vila J, Elosua R, et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health 2007;61:40-7. http://doi.org/dxk72q
10. Marrugat J, D’Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health 2003;57:634-8. http://doi.org/brb9mg
11. Masson W, Lobo M, Huerín M, Molinero G, Manente D, Pángaro M, et al. Use of Different Scores for Cardiovascular Risk Stratification in Primary Prevention and Their Implications in Statin Indication . Rev Argent Cardiol 2014;82:456-461.
12. Brotons C, Calvo-Bonacho E, Moral I, Garcia-Margallo MT, Cortes-Arcas MV, Puig M, et al. Impact of the New American and British Guidelines on the Management and Treatment of Dyslipidemia in a Spanish Working Population. Rev Esp Cardiol (Engl Ed). 2014 Sep 29 [epub ahead of print].
13. Cook NR, Ridker PM. Further Insight Into the Cardiovascular Risk Calculator: The Roles of Statins, Revascularizations, and Underascertainment in the Women’s Health Study. JAMA Intern Med 2014 (en prensa). http://doi.org/wwm
14. Nissen SE. Prevention Guidelines: Bad Process, Bad Outcome. JAMA Intern Med 2014 (en prens).a http://doi.org/wwr
15. Shen L, Shah BR, Reyes EM, Thomas L, Wojdyla D, Diem P, et al. Role of diuretics, beta blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study. BMJ 2013;347:f6745. http:/?doi.org/wwp
16. Pencina MJ, Navar-Boggan AM, D’Agostino RB, Sr, Williams K, Neely B, Sniderman AD, Peterson ED. Application of new cholesterol guidelines to a population-based sample. N Engl J Med 2014;370:1422-31. http://doi.org/vck
17. Vaucher J, Marques-Vidal P, Preisig M, Waeber G, Vollenweider P. Population and economic impact of the 2013 ACC/AHA guidelines compared with European guidelines to prevent cardiovascular disease. Eur Heart J 2014;35:958-9. http://doi.org/wwq